ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 140 filers reported holding ENDOLOGIX INC in Q1 2016. The put-call ratio across all filers is 5.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $8,000 | -65.2% | 11,823 | 0.0% | 0.00% | – |
Q3 2018 | $23,000 | -65.7% | 11,823 | 0.0% | 0.00% | – |
Q2 2018 | $67,000 | +13.6% | 11,823 | -14.7% | 0.00% | – |
Q1 2018 | $59,000 | -41.6% | 13,857 | -27.5% | 0.00% | – |
Q4 2017 | $101,000 | -7.3% | 19,122 | -21.4% | 0.00% | – |
Q3 2017 | $109,000 | +5.8% | 24,333 | +15.5% | 0.00% | – |
Q2 2017 | $103,000 | -32.2% | 21,064 | 0.0% | 0.00% | – |
Q1 2017 | $152,000 | +22.6% | 21,064 | -1.5% | 0.00% | – |
Q4 2016 | $124,000 | -20.5% | 21,374 | +70.0% | 0.00% | – |
Q3 2016 | $156,000 | +2.0% | 12,570 | 0.0% | 0.00% | – |
Q2 2016 | $153,000 | +44.3% | 12,570 | 0.0% | 0.00% | – |
Q1 2016 | $106,000 | +12.8% | 12,570 | +34.9% | 0.00% | – |
Q4 2015 | $94,000 | -15.3% | 9,318 | 0.0% | 0.00% | – |
Q3 2015 | $111,000 | -22.4% | 9,318 | 0.0% | 0.00% | – |
Q2 2015 | $143,000 | -8.3% | 9,318 | 0.0% | 0.00% | – |
Q1 2015 | $156,000 | +7.6% | 9,318 | 0.0% | 0.00% | – |
Q4 2014 | $145,000 | +45.0% | 9,318 | 0.0% | 0.00% | – |
Q3 2014 | $100,000 | – | 9,318 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,121,447 | $5,450,000 | 2.37% |
Essex Woodlands Management, Inc. | 1,257,468 | $11,699,000 | 2.12% |
Redmile Group, LLC | 6,368,299 | $30,950,000 | 1.88% |
Camber Capital Management LP | 7,500,000 | $36,450,000 | 1.78% |
Sio Capital Management, LLC | 493,060 | $2,396,000 | 1.14% |
Rhenman & Partners Asset Management AB | 1,575,000 | $7,655,000 | 1.10% |
PFM Health Sciences, LP | 5,599,466 | $27,213,000 | 0.73% |
Elk Creek Partners, LLC | 2,087,238 | $10,144,000 | 0.66% |
Partner Investment Management, L.P. | 99,736 | $485,000 | 0.65% |
Brown Capital Management | 8,783,162 | $42,686,000 | 0.52% |